Sopharma AD (3JR)
FSX
1.87
-0.12 (-6.03%)
Real-time Data
06:00 AM
Day's Range
1.871.87
52 wk Range
1.502.48
Financial Statements - 3JR - Sopharma AD
Revenue
1.32B▼ 37.6%
Net Income
69.58M▼ 13.5%Net Margin 5.2%
EBITDA
131.08M▼ 19.5%
Free Cash Flow
-63.26M▼ 41.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 1.32B | 2.12B |
| Cost of Goods | 1.01B | 1.67B |
| Gross Profit | 310.51M | 454.04M |
 Operating Expense | - | - |
| Operating Income | 74.43M | 86.57M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 80.57M | 92.08M |
| Income Tax | 10.98M | 11.65M |
| Net Income | 69.58M | 80.43M |
| EPS Basic | 0.193542 | 0.46 |
| EPS Diluted | 0 | 0.46 |
| Basic Shares Outstanding | 343.19M | 164.25M |
| Diluted Shares Outstanding | 343.19M | 164.25M |
| Ebit | 91.69M | 106.52M |
| Ebitda | 131.08M | 162.83M |
| Net Income Continuous Operations | - | - |
| Minority Interests | -3.80M | -4.12M |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
